FSK (FSK) Q1 2026 Earnings Call Transcript

FS KKR Capital reported a 9.9% decline in NAV per share to $18.83, with nonaccruals rising to 8.1% of the portfolio at cost and 4.2% at fair value. Management responded with a $150 million KKR tender at $11 per share, a $150 million convertible preferred investment, a $300 million buyback authorization, and a four-quarter waiver of 50% of the subordinated income incentive fee. NII was $0.42 per share, matching the quarterly distribution, but leverage remained elevated at 131% net debt-to-equity despite a credit facility reset to $4.1 billion and pro forma liquidity of $2.3 billion.

Analysis

FSK is effectively admitting the equity story has become a balance-sheet trade, not a credit-premium compounder. The combination of buybacks, a parent-sponsored tender, and a preferred infusion is a classic attempt to compress the public float and force the market to re-rate the vehicle toward intrinsic value, but it also signals that organic NAV growth is not yet the solution. The most important second-order effect is that management is voluntarily shrinking the platform while trying to preserve fee-bearing earnings, which usually improves per-share optics before it improves absolute earnings power.

Credit deterioration is the real swing factor. Rising nonaccruals and explicit guidance that individual names could worsen suggest the quarter’s marks may not be the end-state; if macro conditions stay soft, further NAV erosion can overwhelm the mechanical accretion from repurchases. The better-than-stated nuance is that the portfolio is likely bifurcating: higher-quality first-lien/ABF assets should de-risk faster, while legacy and lower-liquidity positions remain the source of tail risk and potential surprise write-downs over the next 2-3 quarters.

The market is likely underestimating how much the tender and buyback can act as an implied price floor, but overestimating how quickly that floor translates into a sustainable higher multiple. If the repurchase cadence is paced by repayments, the stock can stay supported near-term while fundamentals lag, creating a window for a trading long but not necessarily a durable investment long. The clearest catalyst stack is 1-2 quarters of stable or improving marks, evidence that rotation is accelerating, and no further nonaccrual surprises; absent that, the preferred and capital-return package just buys time.

Key Decisions for Investors

• Trade long FSK only tactically into the tender window; target 5-10% upside to the implied support level, but size small because downside re-opens if additional nonaccruals surface over the next 1-2 quarters.
• Prefer a pair trade: long KKR / short FSK for 3-6 months. KKR captures the capital-allocation optionality and fee base, while FSK carries the idiosyncratic credit and NAV-destruction risk. This isolates sponsor strength versus troubled vehicle execution.
• If available, buy FSK common only against a hedge of downside via puts or a relative-value short in another BDC with cleaner marks. The trade works if the market over-discounts the asset sale/buyback mechanics, but risk/reward worsens sharply if NAV falls another 5-7%.
• Avoid chasing the preferred until after the first quarter of repurchases is visible; the structure is supportive but still subordinate to portfolio credit. Better entry is after management proves the new capital is reducing leverage rather than masking deterioration.
• For income investors, rotate away from the common into higher-quality BDCs with stable accruals and lower leverage until FSK shows two consecutive quarters of flat-to-up NAV. The near-term yield is not compensating for mark risk.